Related Experiment Videos
From Charcot to SOD1: mechanisms of selective motor neuron death in ALS
1Ludwig Institute for Cancer Research and Department of Medicine and Neuroscience, University of California, San Diego, La Jolla 92093, USA. dcleveland@ucsd.edu
Neuron
|December 14, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant.
Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology·2013
Centromere identity, function, and epigenetic propagation across cell divisions.
Cold Spring Harbor symposia on quantitative biology·2011
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.
Science (New York, N.Y.)·2003
New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes.
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2001
Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation.
Neuropathology : official journal of the Japanese Society of Neuropathology·2001
Toward an automated science of the mind.
Neuron·2026
Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer.
CPT: pharmacometrics & systems pharmacology·2026
The Future of all-Comers Trials in the Era of Precision Oncology.
Clinical pharmacology and therapeutics·2026
MyoD and Myogenin regulatory cascade is targeted by tumor signals to repress myogenesis in cancer cachexia.
The Biochemical journal·2026
Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).
Journal of Alzheimer's disease : JAD·2026
Conferone: Sources, Anticancer Mechanisms, and Potential in Overcoming Chemoresistance - A Comprehensive Review.
Current pharmaceutical design·2026